These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3121896)

  • 1. [Prothrombin complex concentrates in the treatment of hemorrhage in a non-hemophilic patient with a high factor VIII inhibitor level].
    Tsuji K; Takasugi Y; Kumei Y; Namiki M; Kubota K
    Rinsho Ketsueki; 1987 Jul; 28(7):1187-93. PubMed ID: 3121896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated prothrombin complex concentrates in the management of the hemophiliac with Factor VIII inhibitor: case report.
    Griffen AL; Hoots WK; Carter AB
    Pediatr Dent; 1987 Dec; 9(4):321-4. PubMed ID: 3148907
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of inhibitor patients with activated prothrombin complex concentrates.
    Penner JA
    Prog Clin Biol Res; 1984; 150():291-308. PubMed ID: 6431434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating factor VIII inhibitor: case report and review.
    Miles BA; Finn RA
    J Oral Maxillofac Surg; 2005 Feb; 63(2):253-7. PubMed ID: 15690297
    [No Abstract]   [Full Text] [Related]  

  • 6. Postpartum factor VIII inhibitors. Report of two cases with special reference to the efficacy of various treatments.
    Hauser I; Gisslinger H; Locker G; Elbl W; Kyrle PA; Pabinger I; Lechner K
    Wien Klin Wochenschr; 1993; 105(12):355-8. PubMed ID: 8333206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-partum treatment of a patient with a factor VIII inhibitor.
    Files JC; Morrison FS; Halbrook J
    N Engl J Med; 1981 Dec; 305(27):1650. PubMed ID: 6796887
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemorrhagic diathesis (pseudo hemophilia) due to an specific inhibitor of factor VIII].
    Dreyer MS; Omar Lebas J; Willer de Contardi N; Marti ML; Martinez Canaveri A
    Prensa Med Argent; 1970 Mar; 57(1):21-9. PubMed ID: 5454511
    [No Abstract]   [Full Text] [Related]  

  • 9. [A patient with hemorrhage originating from an unknown coagulation pathway inhibitor].
    Komiyama Y; Munakata M; Masuda M; Kagawa H; Fukuhara S; Takahashi H
    Rinsho Byori; 2000 Dec; 48(12):1086-92. PubMed ID: 11215416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of factor VIII and prothrombin complex concentrates in the treatment of inhibitor patients.
    Prentice CR
    Prog Clin Biol Res; 1984; 150():197-206. PubMed ID: 6431428
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitors of factor VIII: detection and treatment.
    Brettler DB
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acquired factor VIII inhibitor in non-hemophilic patients].
    Jensen B; Nielsen VG; Karle H
    Ugeskr Laeger; 1976 Apr; 138(17):1031-3. PubMed ID: 1265887
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased fibrinopeptide A after prothrombin complex concentrates.
    Viganó S; Cattaneo M; Gervasoni W; Mannucci PM
    Thromb Haemost; 1980 Oct; 44(2):72-5. PubMed ID: 6779400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombus precursor protein as a measure of prothrombotic activity in a patient with factor VIII inhibitor treated with activated prothrombin complex concentrates.
    Arkel YS; Bodner R; Ku DH; Lake C; Siciliano F; Lam X
    Thromb Haemost; 1999 Jul; 82(1):152-3. PubMed ID: 10456473
    [No Abstract]   [Full Text] [Related]  

  • 16. Life-threatening sublingual hematoma in a severely hemophilic patient with factor VIII inhibitor.
    Takeuchi M; Shikimori M; Kaneda T
    J Oral Maxillofac Surg; 1986 May; 44(5):401-3. PubMed ID: 3084733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-hemophilic patient with inhibitor against factor VIII produced after the second delivery].
    Akahori M; Yamane T; Hino M; Ohta K; Takubo T; Samori T; Tatsumi N
    Rinsho Byori; 1999 Sep; 47(9):891-5. PubMed ID: 10518429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of factor VIII inhibitor in three non-hemophiliac patients].
    Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M
    Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of prothrombin complex concentrates in the treatment of a hemophilic patient with an inhibitor of factor VIII.
    Sonoda T; Solomon A; Krauss S; Cruz P; Jones FS; Levin J
    Blood; 1976 Jun; 47(6):983-9. PubMed ID: 1276480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired coagulation factor VIII inhibitor in a non-hemophiliac patient].
    Polo Romero FJ; Fernández Fúnez A
    Rev Clin Esp; 1999 Feb; 199(2):114-5. PubMed ID: 10216409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.